Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Paromomycin
Ceva Santé Animale
QA07AA06
Paromomycin
Solution for use in drinking water/milk
POM: Prescription Only Medicine as defined in relevant national legislation
paromomycin
2022-09-02
2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Gabbrovet Multi 140 mg/ml solution for use in drinking water/ milk for pre-ruminant cattle and pigs [FR AT BE BG HR CY CZ EE DE EL HU IE IT LV LT LU NL PL PT RO SK SI ES IS UKNI] Paromocrypto 140 mg/ml solution for use in drinking water/ milk for pre-ruminant cattle and pigs [DK] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Paromomycin (as sulfate): 140.0 mg (equivalent to 140 000 IU of paromomycin activity) (equivalent to approximately 200 mg of paromomycin sulfate) EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS QUANTITATIVE COMPOSITION IF THAT INFORMATION IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE VETERINARY MEDICINAL PRODUC t _ _ Benzyl alcohol (E1519) 7.5 mg Sodium metabisulfite (E223) 3.0 mg Disodium edetate Not applicable Purified water Not applicable After dilution in water, clear colourless or light-yellow solution. After dilution in milk, white to pale yellow liquid. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle (pre-ruminant cattle and newborn calves) and pigs 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES CATTLE (PRE RUMINANT CATTLE):_ _ _Colibacillosis _ Treatment of gastro-intestinal infections caused by _Escherichia coli_ susceptible to paromomycin. CATTLE (NEWBORN CALVES): _Cryptosporidiosis _ Treatment of infections caused by diagnosed _Cryptosporidium parvum_ , by reduction of diarrhoea and reduction of faecal oocyst shedding. Administration has to start within 24 hours after the onset of diarrhoea. PIGS: _Colibacillosis _ Treatment of gastro-intestinal infections caused by _Escherichia coli _ susceptible to paromomycin. 3 3.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to paromomycin, to other aminoglycosides or to any of the excipients. Do not use in cases with impaired function of the kidneys or liver. Do not use in ruminating animals. Do not use in turkeys due to the risk of selection for antimicrobial resistance in intestinal bacteria. 3.4 SPECIAL WARNINGS Cross-re Read the complete document